Multivariate analysis provided additional evidence that higher E2F1 expression proved to be an independent and adverse prognosis factor in SCLC (HR = 0.461, 95% CI: 0.230–0.925, P = 0.029) (Additional file3: Table S2). Here, E2F1 is linked to small cell lung carcinoma.